Diabetic Nephropathies: all 544 studies
Page 5 of 6. Open to participants first (107), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan)CompletedNCT01968668Phase 2
- Impact of Multidisciplinary Self-care Management of Diabetic Nephropathy on Quality of Life, Self-care Behavior, Glycemic Control, and Renal Function.CompletedNCT01967901Not applicable
- To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic NephropathyCompletedNCT01935167Phase 2
- Effect of Green Tea (Epigallocatechin Gallate) on Albuminuria in Patients With Diabetic Nephropathy.CompletedNCT01923597Phase 2
- Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney DiseaseStatus unknownNCT01918488Not applicable
- Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic NephropathyCompletedNCT01889277Phase 1/2
- Mechanisms of Diabetic Kidney Disease in American IndiansCompletedNCT01878045
- Role of Sleep Apnea and Sympathetic Activity in Resistant Hypertensive Patients.CompletedNCT01875341Phase 3
- Effect of Sarpogrelate On the Nephropathy in Type 2 Diabetes (SONATA Study)CompletedNCT01869881Phase 4
- Serum 1,25-dihydroxyvitamin D Levels in Type 2 Diabetes Mellitus Patients With Different Levels of AlbuminuriaCompletedNCT01845870
- Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic NephropathyCompletedNCT01843387Phase 1/2
- Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD)CompletedNCT01829256Not applicable
- Sex-specific Association With Kidney DiseaseCompletedNCT01810822
- Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic NephropathyStatus unknownNCT01796418Not applicable
- Minocycline and Proteinuria in Diabetic NephropathyStatus unknownNCT01779089Not applicable
- SLC2A1 Variants and Diabetic NephropathyCompletedNCT01768611
- A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFRCompletedNCT01756716Phase 2
- A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With AlbuminuriaCompletedNCT01756703Phase 2
- Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic NephropathyStatus unknownNCT01743014Phase 4
- Efficacy and Safety Study of Probucol in Patients With Diabetic NephropathyCompletedNCT01726816Phase 2
- Prevention of Renal Complications of Diabetes With ThiamineStatus unknownNCT01725412Phase 4
- FGF-23 and Endothelial Dysfunction in Diabetic Proteinuric PatientsCompletedNCT01703234Phase 4
- Clinical Trial Technology Development for the Validation of Surrogate Prognostic Markers in Patients With Diabetic NephropathyStatus unknownNCT01673204Phase 4
- Very Low Calorie Diet for Diabetic Kidney DiseaseCompletedNCT01671969Not applicable
- Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood PressureCompletedNCT01667614Phase 2
- Renal Denervation in Diabetic NephropathyCompletedNCT01588795Phase 4
- Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy DeteriorationStatus unknownNCT01566006Not applicable
- Effect of Dietary Protein Restriction on Prognosis in Patients With Diabetic NephropathyCompletedNCT01521910Not applicable
- The Effects of Sevelamer Carbonate on Diabetic NephropathyCompletedNCT01493050Phase 2
- A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy PatientsCompletedNCT01487109Phase 2
- Vitamin D Supplementation in Diabetic NephropathyCompletedNCT01476501Phase 2
- Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney DiseaseStatus unknownNCT01458158
- A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic NephropathyCompletedNCT01447147Phase 2
- A Study to Evaluate the Effect of CCX140-B on Urinary Albumin Excretion in Subjects With Type 2 Diabetes and AlbuminuriaCompletedNCT01440257Phase 2
- Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With AtrasentanCompletedNCT01424319Phase 2
- A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With NephropathyCompletedNCT01399580Phase 2
- Personalized Diabetic Kidney Disease Risk Info to Initiate and Maintain Health Behavior ChangesCompletedNCT01377688
- Impact of c242T Polymorphism of p22phox in Diabetic type1 NephropathyCompletedNCT01371955
- Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) InhibitorCompletedNCT01356849Phase 2
- Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic NephropathyCompletedNCT01331317Phase 4
- Safety, Tolerability, and Pharmacokinetics (PK) of CTP-499CompletedNCT01328821Phase 1
- The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.Active, not recruitingNCT01320345Phase 3
- Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic PatientsStatus unknownNCT01316068Phase 4
- Flavonoids in the Treatment of Endothelial Dysfunction in Children With DiabetesWithdrawnNCT01307917Not applicable
- Low Protein Diet Supplemented With Ketoanalogs on Reducing Proteinuria and Maintaining Nutritional Status in Type 2 Diabetic NephropathyStatus unknownNCT01300273Phase 4
- The Effectiveness of Improving Self-care After Counseling for the Diabetics Mellitus Foots Around Chiayi RegionStatus unknownNCT01299246Phase 1/2
- An Investigation on the Effect of Candesartan on Early Diabetic NephropathyStatus unknownNCT01273675
- A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic NephropathyCompletedNCT01252056Phase 4
- Estimation of Glomerular Filtration Rate (GFR) in Patients With Type 2 Diabetes Mellitus.Status unknownNCT01215994
- A Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) for the Treatment of Chronic Renal Anemia in Participants With Diabetic NephropathyCompletedNCT01191983Phase 4
- To Assess the Accuracy of the eZscan Study in the Screening for Diabetic NephropathyCompletedNCT01163591
- The Effect of Green Tea or Cocoa Extracts in Endothelial Dysfunction in Patients With Diabetes MellitusCompletedNCT01130727Not applicable
- The Effects of Bindarit in Diabetic NephropathyCompletedNCT01109212Phase 2
- Molecular and Clinical Profile of Diabetes Mellitus and Its ComplicationsSuspendedNCT01105858
- Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney DiseaseCompletedNCT01094769Phase 4
- Association of AGTR1 and ACACB Gene Polymorphism and Diabetic Nephropathy in Type 2 DiabetesCompletedNCT01069549
- Effects of PH3 in Diabetic NephropathyCompletedNCT01068041Phase 2
- Pancreas Allotransplantation for Diabetic Nephropathy and Mild Chronic REnal fAilure Stage StudyStatus unknownNCT01067950Phase 3
- Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)CompletedNCT01028287Phase 4
- Effect of Turmeric on Diabetic NephropathyCompletedNCT01015937Not applicable
- Colchicine for Diabetic NephropathyStatus unknownNCT01005121Phase 2
- Evaluating the Renoprotective Effect of Milk Thistle Extract on Patients With Type II Diabetic NephropathyCompletedNCT01003236Phase 2
- Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic NephropathyCompletedNCT00967629Phase 1
- Triple Blockade of the Renin Angiotensin Aldosterone System in Diabetic (Type 1&2) Proteinuric PatientsTerminatedNCT00961207Phase 4
- A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System InhibitorsCompletedNCT00920764Phase 2
- N-Acetylcysteine and Milk Thistle for Treatment of Diabetic NephropathyCompletedNCT00915200Phase 2
- Study of Olmesartan Medoxomil (CS-866) in Patients With Chronic Glomerulonephritis or Diabetic NephropathyCompletedNCT00914524Phase 2
- Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB TherapyTerminatedNCT00913393Phase 2
- A Proof-of-Concept Study of Darbepoetin Alfa in Partial Correction of Anemia in Chinese With Diabetic NephropathyTerminatedNCT00907608Not applicable
- Effect of Renin Angiotensin System Blockade on the Fas Antigen (CD95) and Asymmetric Dimethylarginine (ADMA) Levels in Type-2 Diabetic Patients With ProteinuriaCompletedNCT00893425Phase 4
- Aldosterone in Diabetic NephropathyStatus unknownNCT00870402Phase 4
- Shiga Progression of Diabetes, Nephropathy and RetinopathyStatus unknownNCT00846716Not applicable
- Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney DiseaseCompletedNCT00811889Phase 2
- Evaluation Study for the Programme DiaNe for People With Diabetic NephropathyCompletedNCT00782847Phase 3
- Adiponectin and Insulin Resistance in Diabetic NephropathyCompletedNCT00774904Not applicable
- Phase 1 Study of FG-3019 in Subjects With Type 1 or Type 2 Diabetes Mellitus and Diabetic NephropathyCompletedNCT00754143Phase 1
- Efficacy of Telmisartan and the Combination of Telmisartan and Ramipril in type1 Diabetes Patients With NephropathyCompletedNCT00738660Phase 3
- The Effect of Folic Acid Administration in the Progression of MicroalbuminuriaCompletedNCT00737126Not applicable
- Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 DiabetesCompletedNCT00734253Phase 2
- Adalat XL vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic PatientsWithdrawnNCT00713011Phase 3
- Combined Diabetes-Renal Multifactorial Intervention In Patients With Advanced Diabetic Nephropathy (ADN)CompletedNCT00708981Not applicable
- Phase IIa Trial to Determine the Effects of Bardoxolone Methyl on Renal Function in Patients With Diabetic NephropathyCompletedNCT00664027Phase 2
- Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic NephropathyCompletedNCT00663949Phase 2/3
- Bosentan Use in Patients With Diabetic NephropathyTerminatedNCT00638131Phase 3
- Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT)CompletedNCT00594152Phase 3
- Benfotiamine in Diabetic NephropathyCompletedNCT00565318Phase 4
- Adiponectin in Obese Women With T2DN and Effects by RAS BlockerCompletedNCT00561704Not applicable
- Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and MicroalbuminuriaTerminatedNCT00557518Phase 2
- Efficacy of N-Acetylcysteine in Treatment of Overt Diabetic NephropathyCompletedNCT00556465Phase 2/3
- Multiple Dose Trial of Anti-glycation Agent GLY-230 in Healthy and Diabetic SubjectsCompletedNCT00544934Phase 1/2
- To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN)CompletedNCT00518362Not applicable
- Spironolactone for Reducing Proteinuria in Diabetic NephropathyCompletedNCT00498537Not applicable
- Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care ProgramStatus unknownNCT00498147
- Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based StudyStatus unknownNCT00497666
- Chicken-Diet vs. Enalapril to Reduce AlbuminuriaCompletedNCT00484068Not applicable
- Effects of Aliskiren, Irbesartan, and the Combination in Hypertensive Patients With Type 2 Diabetes and Diabetic NephropathyCompletedNCT00464880Phase 1/2
- Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong KongTerminatedNCT00462202Phase 3
- Effect of Low Protein Diet in Preventing the Progression of Diabetic NephropathyTerminatedNCT00448526Not applicable
- Glucose in Dialysis Water in Diabetics With Chronic Renal FailureCompletedNCT00438503Phase 4
- Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes MellitusCompletedNCT00419835Phase 4